May 01, 2020
Lupin Pharmaceuticals Inc. is recalling more than 11,000 bottles of 20-mg lisinopril tablets after a customer reported finding 10-mg tablets in two sealed 20-mg tablet bottles. The recall was included in the April 29, 2020, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects lisinopril tablets, 20 mg, 1000-count bottles (NDC 68180-0981-03) from lot Q000255 (Exp. 1/22). The product was distributed throughout the United States.
Lupin Pharmaceuticals initiated the recall April 20, 2020. The FDA designated the recall Class II on April 21, 2020, signaling use of the product could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists.
Lisinopril is a prescription angiotensin converting enzyme (ACE) inhibitor used to treat high blood pressure and heart failure, and to reduce the risk of death after heart attack